fbpx

Dry Eye Rescue Is Offering Friends Of MDA A 20% Discount On All Products To Help With Your Eye Conditions

Click Here To Save Now

Resources

Oct 7, 2024

Metformin Shows Promise for Treating Macular Degeneration in Mice

A new study shows metformin may help prevent vision loss associated with age-related macular degeneration. News Published: October 7, 2024 Original story from the University of Chicago Age-related macular degeneration…

Metformin Shows Promise for Treating Macular Degeneration in Mice

Sep 23, 2024

Alkeus Pharmaceuticals announces results from the SAGA study of oral gildeuretinol in patients with GA

September 19, 2024 By David Hutton Oral gildeuretinol demonstrated a clinically meaningful reduction in the geographic atrophy lesion growth rate at 24 months, supporting additional clinical development. SAGA topline data has…

Alkeus Pharmaceuticals announces results from the SAGA study of oral gildeuretinol in patients with GA

Sep 19, 2024

Eye Drop Company in FDA’s Sights Once Again

The agency sounds alarm that products still may contain amniotic fluid by Kristina Fiore, Director of Enterprise & Investigative Reporting, MedPage Today September 17, 2024 The FDA has sent another letter — this…

Eye Drop Company in FDA’s Sights Once Again

Sep 16, 2024

These foods sabotage sleep

By Julia Ries | Fact-checked by Davi Sherman | Published September 13, 2024 Key Takeaways Certain foods like chocolate, greasy snacks, and spicy dishes can disrupt sleep due to their effects on digestion and caffeine content.…

These foods sabotage sleep

Sep 12, 2024

The Changing Landscape of Nutrition in Medicine

A look at developments that have propelled us forward and those still to come for eye care. by: Julie Poteet, OD, MS, CNS, FOWNS At A Glance The increasing prevalence…

The Changing Landscape of Nutrition in Medicine

Sep 11, 2024

Up to 1 in 5 Dementia Cases May Be Attributable to Vision Impairment

Contrast sensitivity impairment showed the strongest relationship by Judy George, Deputy Managing Editor, MedPage TodaySeptember 5, 2024 Last Updated September 6, 2024 Key Takeaways Up to 19% of prevalent dementia cases may be…

Up to 1 in 5 Dementia Cases May Be Attributable to Vision Impairment

Sep 9, 2024

AiViva Biopharma completes enrollment in Phase 1 clinical trial of AIV007 for AMD, DME

By David Hutton The Phase 1 trial is a multicenter, open-label, dose-escalation safety clinical trial, with 18 subjects, who each have received a single periocular injection of AIV007 AiViva Biopharma Inc…

AiViva Biopharma completes enrollment in Phase 1 clinical trial of AIV007 for AMD, DME

Aug 21, 2024

AOA urges eye care provider consultation before use, purchase of MSM eye drops

August 20, 2024, By Jordana Joy, Associate Editor The alert follows a warning letter issued by the US FDA to a company that manufactures eye drops that claim to change eye…

AOA urges eye care provider consultation before use, purchase of MSM eye drops

Aug 15, 2024

Prevalence of AMD-related vision loss expected to increase as population ages

By Kate YoungFact checked by Heather Biele Key takeaways: Prevalence of AMD-related blindness decreased globally from 2000 to 2020. Older age is associated with greater prevalence of AMD-related vision loss.…

Prevalence of AMD-related vision loss expected to increase as population ages

Aug 12, 2024

Sandoz announces FDA approval for new biosimilar

New Press Release The U.S. Food and Drug Administration (FDA) has approved Sandoz biosimilar Enzeevu™ (aflibercept-abzv) 2 mg vial kit and pre-filled syringe for intravitreal injection. Enzeevu is indicated to…

Sandoz announces FDA approval for new biosimilar

Aug 12, 2024

Multivitamins could potentially shorten your lifespan

By Lisa Marie Basile | Fact-checked by Davi Sherman | Published July 16, 2024 Key Takeaways A new cohort study published in JAMA Network Open analyzed data from nearly 400,000 participants over 20 years and found that the use…

Multivitamins could potentially shorten your lifespan

Aug 9, 2024

Ocular Therapeutix receives FDA nod for SOL-R registrational study of Axpaxli

New Study Ocular Therapeutix obtained FDA support to use the phase 3 SOL-R trial as the next step in the regulatory process for Axpaxli, according to a press release. The FDA…

Ocular Therapeutix receives FDA nod for SOL-R registrational study of Axpaxli

Aug 6, 2024

AREDS2 supplement slows expansion of geographic atrophy, even in late-stage AMD

by: Steven Ferrucci, OD, FAAO Key takeaways: The AREDS2 supplement slowed the expansion of geographic atrophy toward the fovea by approximately 55% over 3 years in patients with dry AMD.…

AREDS2 supplement slows expansion of geographic atrophy, even in late-stage AMD

Jul 28, 2024

Stave off cognitive decline: Eat this mushroom

By Julia Ries | Fact-checked by Davi Sherman | Published July 25, 2024 Key Takeaways The lion’s mane mushroom is gaining popularity for its potential health benefits, particularly in supporting memory and preventing cognitive decline. Mushrooms, including…

Stave off cognitive decline: Eat this mushroom

Jul 26, 2024

Heart Pounding, Stomach-Knotting: Stress & You

The Stress Response Your muscles tense, your heart races and your breath comes faster — we all know what stress feels like. The “fight or flight” response is behind it:…

Heart Pounding, Stomach-Knotting: Stress & You

Jul 25, 2024

Could Metformin Fill the Bill for Geographic Atrophy Prevention?

Case-control study shows reduction in new-onset GA, particularly in nondiabetic patients by Charles Bankhead, Senior Editor, MedPage TodayJuly 22, 2024 STOCKHOLM — The risk of developing geographic atrophy (GA) declined significantly in…

Could Metformin Fill the Bill for Geographic Atrophy Prevention?

Jul 8, 2024

FDA approves Vabysmo prefilled syringe for retinal diseases

Key takeaways: The prefilled syringe is indicated for wet age-related macular degeneration, diabetic macular edema, and retinal vein occlusion. The syringe will be available in the U.S. later this year.…

FDA approves Vabysmo prefilled syringe for retinal diseases

Jul 1, 2024

AI model helps predict anti-VEGF response in diabetic macular edema

KIAWAH ISLAND, S.C. — In this Healio Video Perspective from Kiawah Eye, Joe Luvisi, MD, discusses the use of AI to predict response to anti-VEGF therapy in diabetic macular edema. Luvisi and…

AI model helps predict anti-VEGF response in diabetic macular edema

Jun 25, 2024

Utilizing the immune system to combat dry eye disease

by: Walter O. Whitley OD, MBA, FAAO Exploring strategies for effective management of a multifaceted condition Dry eye disease (DED) is a chronic and often progressive condition that can be…

Utilizing the immune system to combat dry eye disease

Jun 25, 2024

Pegcetacoplan injection preserves visual function at 36 weeks in patients with geographic atrophy

By: David Hutton Positive data from the GALE long-term extension study showed patients developed fewer new scotomatous points with 36 months of both continuous monthly and every-other-month treatment. A study…

Pegcetacoplan injection preserves visual function at 36 weeks in patients with geographic atrophy

Jun 11, 2024

FDA clears OTC CGMs for general public, adults with type 2 diabetes who do not use insulin

Key takeaways: The Abbott Libre Rio was cleared for adults with type 2 diabetes who do not use insulin. The FDA cleared the Abbott Lingo for adults who want to…

FDA clears OTC CGMs for general public, adults with type 2 diabetes who do not use insulin

Jun 10, 2024

SYFOVRE® (pegcetacoplan injection) Preserved Visual Function at 36 Months in GALE Extension Study in Geographic Atrophy (GA)

June 10, 2024 SYFOVRE is the only approved GA treatment to demonstrate a visual function benefit in a prespecified endpoint Data presented at the Clinical Trials at the Summit Meeting…

SYFOVRE® (pegcetacoplan injection) Preserved Visual Function at 36 Months in GALE Extension Study in Geographic Atrophy (GA)

Jun 6, 2024

Avirmax Biopharma Inc receives IND approval from FDA

June 6, 2024 by: Martin David Harp The IND approval will allow the company to initiate a Phase I/IIa clinical trial for its gene therapy treatment targeting wet Age-related Macular…

Avirmax Biopharma Inc receives IND approval from FDA

Jun 6, 2024

Stealth BioTherapeutics enrols first subject in dry AMD treatment trial

A new dry AMD study. The rate of change in the macular area of photoreceptor loss is the primary efficacy endpoint of ReNEW and ReTAIN trials. Stealth BioTherapeutics has enrolled…

Stealth BioTherapeutics enrols first subject in dry AMD treatment trial

May 30, 2024

FDA Grants AI-Powered Notal Vision Home OCT “SCANLY” De Novo Marketing Authorization

      First-ever home retinal imaging service to monitor wet AMD, the leading cause of blindness for older patients Manassas, VA (May 16, 2024) Digital healthcare provider, Notal Vision,…

FDA Grants AI-Powered Notal Vision Home OCT “SCANLY” De Novo Marketing Authorization

May 30, 2024

Study: Low-dose aspirin doesn’t affect the incidence or progression of AMD

May 28, 2024, by; Lynda Charters Investigators undertook a secondary analysis of the effects of long-term, low-dose aspirin in over 3,000 older adults who satisfied the inclusion criteria in the…

Study: Low-dose aspirin doesn’t affect the incidence or progression of AMD

May 22, 2024

Press Release

Discover Hope Macular Degeneration Association Connects Patients with Vital Support Macular Degeneration Association offers free resources and events for all SARASOTA, Fla. (May 14, 2024) – The Macular Degeneration Association…

Press Release

May 12, 2024

Happy Mother’s Day

                                                           …

Happy Mother’s Day

May 3, 2024

16 Ways to Modify Your Home if You Have Diabetic Macular Edema

Low vision can increase your risk of a fall or other mishap. Here’s a room-by-room guide to making your home safer if you have DME. By Maria Masters Medically Reviewed …

16 Ways to Modify Your Home if You Have Diabetic Macular Edema

May 3, 2024

Study finds link between body weight and retinal thickness

There appears to be a significant association between body weight, specifically preobesity and obesity, and changes in retinal thickness, according to a study that suggests individuals who are preobese, even…

Study finds link between body weight and retinal thickness

Newsletter Sign-up

  • This field is for validation purposes and should be left unchanged.